Colgate-Palmolive Company

Form 483 issued July 15, 2021 · Morristown, Tennessee

Inspection
Jul 12 – Jul 15, 2021
Observations
4
Pages
5
FEI number
3005874880

In short: On July 15, 2021, FDA issued a Form 483 with 4 observations to Colgate-Palmolive Company in Morristown, Tennessee (FEI 3005874880) after an inspection that ran Jul 12 – Jul 15, 2021. The investigators were Benjamin E. Bowen and Gamal A. Norton. Most observations concern cAPA and production & process controls.

At a glance

CAPA and production & process controls account for 4 of 4 observations.

CAPA2
Production & process controls2

What FDA observed

Preview: the opening words of each observation
  1. 01

    MDR event files do not contain or reference all adverse event information in the possession of…

  2. 02

    Procedures for monitoring and control of process parameters for a validated process have…

  3. 03

    Complaints involving the possible failure of a device and packaging to meet any of its specifications…

  4. 04

    Procedures to ensure equipment is routinely calibrated have…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Colgate-Palmolive Company?

FDA listed 4 observations on this Form 483, mostly about cAPA and production & process controls. The opening words of each observation are shown on this page.

Who inspected Colgate-Palmolive Company?

Benjamin E. Bowen and Gamal A. Norton are named on this Form 483, for the inspection of Jul 12 – Jul 15, 2021. Each investigator has a profile showing what they cite most.

When was Colgate-Palmolive Company inspected by FDA?

The inspection ran Jul 12 – Jul 15, 2021, and the Form 483 is dated July 15, 2021.

How do I get the full Form 483 for Colgate-Palmolive Company?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free